APA (7th ed.) Citation

LA, O., J, N., J, P., EW, K., N, I., P, M., . . . P, A. (2026). The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol. PloS one, 21(3), e0330792. https://doi.org/10.1371/journal.pone.0330792

Chicago Style (17th ed.) Citation

LA, Ombajo, et al. "The Dolutegravir Failure Cohort: A Multi-country Longitudinal Cohort with a Randomised Clinical Trial of Continued Dolutegravir Versus Switch to Darunavir in People with Viraemia While on Dolutegravir in Sub-Saharan Africa (The Ndovu Study) Protocol." PloS One 21, no. 3 (2026): e0330792. https://doi.org/10.1371/journal.pone.0330792.

MLA (9th ed.) Citation

LA, Ombajo, et al. "The Dolutegravir Failure Cohort: A Multi-country Longitudinal Cohort with a Randomised Clinical Trial of Continued Dolutegravir Versus Switch to Darunavir in People with Viraemia While on Dolutegravir in Sub-Saharan Africa (The Ndovu Study) Protocol." PloS One, vol. 21, no. 3, 2026, p. e0330792, https://doi.org/10.1371/journal.pone.0330792.